Fig. 1. Comparison of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (Ph+ ALL) subjects with the CD34+CD38-CD58- phenotype versus other phenotypes regarding the rate of complete remission (CR) after induction chemotherapy.

Blood Res 2018;53:138~144 https://doi.org/10.5045/br.2018.53.2.138